Asset Details
Do you wish to reserve the book?
Incidental diagnosis of HLRCC following investigation for Asperger Syndrome: actionable and actioned
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Incidental diagnosis of HLRCC following investigation for Asperger Syndrome: actionable and actioned
Do you wish to request the book?
Incidental diagnosis of HLRCC following investigation for Asperger Syndrome: actionable and actioned
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Incidental diagnosis of HLRCC following investigation for Asperger Syndrome: actionable and actioned
2016
Overview
Incidental findings are inevitable as clinical research and practice transitions from a single gene approach to a genomic approach. A novel deletion of the
Fumarate Hydratase
(
FH
) gene was identified in a 22 year old male who underwent a molecular karyotype as part of an autism spectrum disorder research project. This unexpected result implies a predisposition to Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC), a rare, autosomal dominant condition and has unforeseen implications for him and his family. We review the typical features and management of HLRCC and discuss the challenges that face health professionals, as genetic testing advances and becomes more accessible.
Publisher
Springer Netherlands,Springer Nature B.V
